In melanoma and colon tumor cells deletion of Tet2 reduced chemokine expression and tumor-infiltrating lymphocytes, enabling tumors to evade antitumor immunity and to resist anti-PD-L1 therapy18. Here, CD274 is linked to neoplasm.